The Reagan Udall Foundation – A Critical Evaluation of FDA’s Center for Tobacco Products 

I.      Reagan-Udall Report In July 2022, the Food and Drug Administration (FDA) Commissioner, Dr. Robert Califf, released a public statement saying the agency “has confronted a series of challenges that have tested our regulatory frameworks and stressed the agency’s operations.” As such, Commissioner Califf was “prompt[ed] . . . to take a closer look at how... Continue Reading